Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types

NCT03869814•ClearNote Health

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Diagnosis of Cancer of Various Organs

Interventions

Blood Draw

Locations

United States

Locations (1)

Bluestar Genomics, Inc.

San Diego, California, United States

Key Dates

Start Date

April 5, 2018

Primary Completion Date

June 13, 2023

Completion Date

September 13, 2023

Last Updated

May 5, 2022

Contacts

Melissa Peters, MA, PMP, CCRC

CONTACT

619-277-2160 mpeters@bluestargenomics.com

Sponsors

Lead Sponsor

ClearNote Health

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 5, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions